Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Werewolf Therapeutics (HOWL) Invested Capital (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Invested Capital for 5 consecutive years, with $24.8 million as the latest value for Q4 2025.

  • Quarterly Invested Capital fell 66.2% to $24.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24.8 million through Dec 2025, down 66.2% year-over-year, with the annual reading at $24.8 million for FY2025, 66.2% down from the prior year.
  • Invested Capital for Q4 2025 was $24.8 million at Werewolf Therapeutics, down from $29.6 million in the prior quarter.
  • The five-year high for Invested Capital was $181.6 million in Q2 2021, with the low at -$153.8 million in Q1 2021.
  • Average Invested Capital over 5 years is $93.7 million, with a median of $115.0 million recorded in 2023.
  • The sharpest move saw Invested Capital surged 190.61% in 2022, then plummeted 66.87% in 2025.
  • Over 5 years, Invested Capital stood at $152.8 million in 2021, then fell by 19.93% to $122.3 million in 2022, then decreased by 8.96% to $111.4 million in 2023, then crashed by 34.1% to $73.4 million in 2024, then plummeted by 66.2% to $24.8 million in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at $24.8 million, $29.6 million, and $41.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.